Description: Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The Beyond Air NO Delivery System can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM).
Home Page: www.beyondair.net
XAIR Technical Analysis
900 Stewart Avenue
Garden City,
NY
11530
United States
Phone:
516 665 8200
Officers
| Name | Title |
|---|---|
| Mr. Steven Adam Lisi | CEO & Chairman |
| Mr. Amir Avniel | Co-Founder, Chief Bus. Officer & Director |
| Mr. Douglas Quinton Larson | CFO, Principal Financial Officer & Principal Accounting Officer |
| Mr. Michael A. Gaul | Chief Operating Officer |
| Edward Barger | Head of Investor Relations |
| Mr. Adam Newman | Chief Legal Officer & Gen. Counsel |
| Ms. Rebecca Van Doren | Head of Sales |
| Ms. Kori-Ann Taylor | Head of Marketing |
| Prof. Andrew R. Colin M.D. | Chief Medical Officer & Member of Scientific Advisory Board |
| Dr. Giora Davidai M.D. | Chief Medical Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.9451 |
| Price-to-Sales TTM: | 932.7421 |
| IPO Date: | 2017-09-22 |
| Fiscal Year End: | March |
| Full Time Employees: | 62 |